麥克奧迪(300341.SZ):控股股東等與鄭眾喜就北京優納相關控制權簽署戰略合作框架協議
格隆匯3月7日丨麥克奧迪(300341.SZ)公佈,2022年03月04日公司董事會審議通過了與控股股東北京亦莊投資控股有限公司(簡稱“亦莊控股”)、董事兼總經理楊澤聲、RY Investment Company、鄭眾喜簽署《戰略合作框架協議》的議案,約定由楊澤聲及其控制的RY Investment Company收購鄭眾喜實際控制的北京優納科技有限公司(簡稱“北京優納”,北京優納及其下屬全資及控股子公司合稱為“優納集團”)控制權。待優納集團滿足相關條件後,公司享有優先收購優納集團的主動權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.